Verona Pharma

NASDAQ: VRNA · Real-Time Price · USD
73.90
-1.71 (-2.26%)
At close: May 28, 2025, 3:59 PM

Verona Pharma Revenue Breakdown

Period Ending Dec 31, 2024
Product and Service, Other Revenue 18K
Product and Service, Other Revenue Growth n/a
Product Revenue 42.26M
Product Revenue Growth n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Dec 31, 2015
Selling, General, and Administrative Revenue 69.11M 45.09M 35.2M 48.82M 20.16M 14.89M 13.35M 12.44M 9.59M 8.32M 5.29M 5.53M 7.44M 5.76M 10.88M 7.99M 9.28M 11.69M 8.46M 2.85M 6.56M -2.17M 2.42M 2.7M 2.39M 1.93M 1.85M 2.32M 2.04M 1.34M 2.73M 2.56M 1.29M 1.04M 979.74K 467.78K n/a
Selling, General, and Administrative Revenue Growth +53.29% +28.10% -27.91% +142.17% +35.37% +11.53% +7.35% +29.72% +15.21% +57.33% -4.27% -25.73% +29.23% -47.10% +36.29% -13.97% -20.59% +38.23% +196.75% -56.54% -402.74% -189.36% -10.20% +13.03% +23.70% +4.57% -20.31% +13.38% +52.18% -50.88% +6.72% +98.91% +24.40% +5.65% +109.44% n/a n/a
Research and Development Revenue 14.05M 7.87M 10.55M 19.41M 6.76M 4.16M 2.96M -2.47M 12.61M 6.84M 9.84M 14.98M 17.63M 22.71M 22.56M 20.56M 13.57M 16.36M 12.7M 7.64M 7.26M 5.66M 14.71M 12.57M 7.73M 6.7M 6.97M 5.08M 6.2M 13.26M 8.15M 6.29M 3.87M 2.12M 1.84M 696.94K n/a
Research and Development Revenue Growth +78.58% -25.42% -45.64% +187.12% +62.59% +40.56% -219.56% -119.62% +84.41% -30.49% -34.33% -15.00% -22.39% +0.66% +9.71% +51.49% -17.01% +28.75% +66.39% +5.12% +28.31% -61.53% +17.10% +62.53% +15.42% -3.82% +37.24% -18.09% -53.27% +62.64% +29.51% +62.48% +82.60% +15.58% +163.37% n/a n/a